This week’s newsletter covers federal threats to state cannabis rights, a controversial hemp redefinition proposal, safety concerns around rolling papers, promising CBD research on liver cancer, and new findings on psilocybin therapy for alcohol use disorder and disordered eating.
Noteworthy Read
How the Trump Administration Is Working to Undermine States’ Cannabis Rights (The Hill)
This recent op-ed examines how the Trump administration is undermining states’ rights by pursuing federal actions that could restrict access to medical marijuana, contradicting earlier promises to leave cannabis policy up to individual states.
Continue reading
View more in THC
More Noteworthy Reading
Proposed Revised Hemp Definition Creates Backlash (Hemp Gazette)
A new proposal to redefine hemp at the federal level is drawing criticism from stakeholders who say it could criminalize non-intoxicating products and jeopardize small businesses operating in the grey area established under the 2018 Farm Bill.
Printed and Dyed Rolling Papers Could Pose Health Risks (MJBizDaily)
New research suggests that colorful and printed rolling papers may contain heavy metals and toxins, raising safety concerns for consumers and prompting calls for tighter product regulations.
CBD a Potential Agent for Liver Cancer (PubMed)
A recent preclinical study highlights cannabidiol’s (CBD) anti-tumor properties in liver cancer, showing it may inhibit cell proliferation and induce apoptosis, suggesting promise as an adjunctive therapeutic.
Research Round-Up
Single-Dose Psilocybin Therapy Shows Promise for Reducing Alcohol Consumption (PsyPost)
New clinical findings suggest that even one session of psilocybin-assisted therapy can significantly reduce alcohol intake, offering potential for treating alcohol use disorder.
Read more
View more in Psychedelics
The Role of Psychedelic Experience on Wellbeing and Disordered Eating (MDPI)
This study explores how meaningful psychedelic experiences—especially those involving ego dissolution—are associated with improved psychological wellbeing and reduced symptoms of disordered eating.
Read more
View more in Psychedelics
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to shine a light on the plant medicine research and stories that matter most. We’re grateful for every one of you.
